Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec 29;26(1):115.
doi: 10.3390/molecules26010115.

Synthesis of Galectin Inhibitors by Regioselective 3'- O-Sulfation of Vanillin Lactosides Obtained under Phase Transfer Catalysis

Affiliations

Synthesis of Galectin Inhibitors by Regioselective 3'- O-Sulfation of Vanillin Lactosides Obtained under Phase Transfer Catalysis

Karima Belkhadem et al. Molecules. .

Abstract

Vanillin-based lactoside derivatives were synthetized using phase-transfer catalyzed reactions from per-O-acetylated lactosyl bromide. The aldehyde group of the vanillin moiety was then modified to generate a series of related analogs having variable functionalities in the para- position of the aromatic residue. The corresponding unprotected lactosides, obtained by Zemplén transesterification, were regioselectively 3'-O-sulfated using tin chemistry activation followed by treatment with sulfur trioxide-trimethylamine complex (Men3N-SO3). Additional derivatives were also prepared from the vanillin's aldehyde using a Knoevenagel reaction to provide extended α, β-unsaturated carboxylic acid which was next reduced to the saturated counterpart.

Keywords: Knoevenagel-Doebner reaction; cancer; galectins; lactosides; phase transfer catalysis; sulfation; vanillin.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. The founding sponsors had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, and in the decision to publish the results

Figures

Figure 1
Figure 1
Top panel: Synthetic strategy for simultaneous modifications of lactose at the anomeric position with aromatic vanillin aglycon together with incorporating an anionic sulfate group at O-3′. Lower panel: Left panel: Predicted Connelly surface of the Gal-8 N-terminal (PDB 3AP6) with docked compound 12 that was superimposed to the original O-3′-sulfated lactose. Right panel: Schematic representation of Gal-8 N-terminal illustrating the beta strands and Arg45 and Arg59 (S4 section) are clearly in electrostatic contact with the sulfate group [4,27].
Scheme 1
Scheme 1
Phase Transfer Catalysis (PTC)-catalyzed synthetic steps leading to vanillin-based lactosides 58 using peracetylated lactosyl bromide 1 and vanillin derivatives 24.
Scheme 2
Scheme 2
Tin acetal catalyzed regioselective 3′-O-sulfation of vanillin derivatives 58.
Scheme 3
Scheme 3
Knoevenagel–Doebner condensation reaction for the synthesis of α, β-unsaturated lactosides 1720.

Similar articles

Cited by

References

    1. Solís D., Bovin N.V., Davis A.P., Jiménez-Barbero J., Romero A., Roy R., Smetana Jr K., Gabius H.-J. A guide into glycosciences: How chemistry and biochemistry cooperate to crack the sugar code. Biochim. Biophys. Acta. 2015;1850:186–235. - PubMed
    1. Johannes L., Jacob R., Leffler H. Galectins at a glance. J. Cell Sci. 2018;131:1–8. doi: 10.1242/jcs.208884. - DOI - PubMed
    1. Girotti M.R., Salatino M., Dalotto-Moreno T., Rabinovich G.A. Sweetening the hallmarks of cancer: Galectins as multifunctional mediators of tumor progression. J. Exp. Med. 2020;217:1–14. doi: 10.1084/jem.20182041. - DOI - PMC - PubMed
    1. Roy R., Murphy P.V., Gabius H.-J. Multivalent Carbohydrate-Lectin Interactions: How Synthetic Chemistry Enables Insights into Nanometric Recognition. Molecules. 2016;21:629. doi: 10.3390/molecules21050629. - DOI - PMC - PubMed
    1. Hockl P.F., Wolosiuk A., Pérez-Sáeza J.M., Bordoni A.V., Crocia D.O., Toum-Terrones Y., Soler-Illia G.J.A.A., Rabinovich G.A. Glyco-nano-oncology: Novel therapeutic opportunities by combining small and sweet. Pharmacol. Res. 2016;109:45–54. doi: 10.1016/j.phrs.2016.02.005. - DOI - PubMed

LinkOut - more resources